Keppra and Ferriprox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Ferriprox (deferiprone). Common drug interactions include death among females and infection among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Ferriprox. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Ferriprox?

Ferriprox has active ingredients of deferiprone. eHealthMe is studying from 1,991 Ferriprox users. Check the latest studies of Ferriprox.



On Jul, 08, 2026

33 people who take Keppra and Ferriprox together, and have interactions are studied.

Keppra and Ferriprox drug interactions.

What are the common drug interactions of Keppra and Ferriprox, by gender? *:

female:

  1. Death
  2. Pain
  3. Alopecia (absence of hair from areas of the body)
  4. Cardiac arrest
  5. Cardiac murmur (an heart sound in valve abnormality)
  6. Depression
  7. Dry skin
  8. Fistula (an abnormal connection or passageway between two)
  9. Glomerular filtration rate decreased
  10. Muscle spasms (muscle contraction)

male:

  1. Infection
  2. Acute respiratory failure
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Blood alkaline phosphatase increased
  6. Diarrhoea
  7. Muscle spasms (muscle contraction)
  8. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  9. Blood glucose increased
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Keppra and Ferriprox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Nasopharyngitis (inflammation of the nasopharynx)

10-19:

  1. Pain

20-29:

  1. Neuropathy peripheral (surface nerve damage)
  2. Tendonitis (a condition that causes pain and swelling of tendons)
  3. Death
  4. Ill-defined disorder

30-39:

  1. Death
  2. Diarrhoea

40-49:

  1. Muscle spasms (muscle contraction)
  2. Blood glucose increased
  3. Renal impairment (severely reduced kidney function)
  4. Blood iron increased
  5. Cardiac arrest
  6. Drug ineffective
  7. Ill-defined disorder
  8. Overdose

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Depression
  3. Dry skin
  4. Onychoclasis (breaking of the nails)
  5. Pain

60+:

n/a

What are the existing conditions these people have? *

  1. Haemochromatosis (body to absorb more iron than usual from food): 27 people, 81.82%
  2. Pain: 3 people, 9.09%
  3. Basal Ganglion Degeneration (loss of brain tissue in the cortex, or outer layer of the brain): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Ferriprox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra and Ferriprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ferriprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ferriprox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and deferiprone (the active ingredients of Keppra and Ferriprox, respectively), and Keppra and Ferriprox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: